Microchannel Red Blood Cell Rigidity Measurement for Glycated Hemoglobin

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Conventional glycated hemoglobin level measuring devices are complex, inaccessible, and have limitations in accuracy and usability for home-based management, necessitating improved methods for accessible and reliable measurement.

Innovation Solution

A device utilizing microchannel technology to measure glycated hemoglobin levels based on physical characteristics of red blood cells, such as stiffness, through a system with electrodes and microchannels to determine travel time and rigidity, enabling accurate home-based monitoring.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Measurement precision

If conventional glycated hemoglobin measuring devices are used, then measurement accuracy is maintained, but device complexity and accessibility are worsened

Engineering Contradiction:
Improveglycated hemoglobin measurement accuracyVSAvoiddevice complexity
Core Design Contradiction:
Measurement precisionVSDevice complexity

Solution Approach 1:

The patent replaces complex biochemical measurement systems with a mechanical/physical measurement system. Specifically, it measures glycated hemoglobin by detecting changes in red blood cell physical properties (stiffness, deformability) as they pass through a microchannel, rather than using complex biochemical reagents and instrumentation. This substitution maintains measurement accuracy while dramatically simplifying the device architecture.

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

Solution Approach 2:

The invention measures glycated hemoglobin levels by detecting changes in physical parameters of red blood cells (stiffness, deformability, passage time) rather than directly measuring chemical composition. Glycated hemoglobin alters the physical properties of red blood cells, and these parameter changes are detected as the cells traverse a constricted microchannel, providing an accurate but simplified measurement approach.

Inventive Principle:
Principle #35Parameter changes

2Reliability

If conventional glycated hemoglobin measuring devices are used, then measurement reliability is maintained, but ease of operation and accessibility are worsened

Engineering Contradiction:
Improvemeasurement reliabilityVSAvoidease of operation
Core Design Contradiction:
ReliabilityVSEase of operation

Solution Approach 1:

The device requires minimal user intervention and preparation. A simple blood sample (even from a finger prick) is introduced into the microchannel, and the system automatically performs the measurement by detecting red blood cell physical properties. No complex sample preparation, reagent handling, or specialized training is needed, making the device easy for patients to operate at home while maintaining reliable measurements.

Inventive Principle:
Principle #25Self-service

3Ease of operation

If biochemical methods are used for home-based measurement, then accessibility is improved, but measurement accuracy and component lifespan are worsened

Engineering Contradiction:
Improvehome-based accessibilityVSAvoidmeasurement accuracy
Core Design Contradiction:
Ease of operationVSMeasurement precision

Solution Approach 1:

The patent employs a disposable microchannel chip that contains the measurement structure. After a single use, the chip is discarded, eliminating the need for cleaning, sterilization, or maintenance. This disposable approach ensures consistent measurement accuracy across multiple uses while making the device simple and accessible for home-based diabetes management.

Inventive Principle:
Principle #27Cheap short-living objects (Disposable)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

Provides accurate and accessible measurement of glycated hemoglobin levels, allowing continuous management and personalized health monitoring, enhancing diabetes management through real-time data analysis and feedback.

Implementation Method 1

the microchannel can have one or more dimensions less than that/those of the red blood cells, thereby compressing the red blood cells that travel through the microchannel

Methodology Applied
Scientific EffectCompression: Compression

Implementation Method 2

a first sensor couplable to the first pair of electrodes and configured to measure a change in an electrical property (e.g., an impedance across the first detection region)

Methodology Applied
Scientific EffectElectrical impedance: Electrical Resistance

Data Source

PatentUS12399185B2Apparatus for measuring glycation of red blood cells and glycated hemoglobin level using physical and electrical characteristics of cells, and related methods
Publication Date: 2025.08.26 ORANGE BIOMED CO LTD
  • US12399185B2 patent drawing
  • US12399185B2 patent drawing
  • US12399185B2 patent drawing

AI summary

The present disclosure relates to systems and methods for measuring glycated A1c hemoglobin. A glycated hemoglobin level measuring system includes a sample testing apparatus having a microchannel that compresses a blood sample traveling through, a first pair of electrodes coupled to the microchannel, and a second pair of electrodes coupled to the microchannel. The glycated hemoglobin level measuring system further includes an analysis apparatus having sensors coupled to the first and second pairs of electrodes and configured to calculate a travel time taken by a red blood cell to pass through the first and second pairs of electrodes. The glycated hemoglobin level measuring system can use the travel time to measure a rigidity of the red blood cells and the corresponding glycated hemoglobin level.